Clinical Trial Update: Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 1/Phase 2 study evaluating the combination of ifosfamide, teniposide, and paclitaxel in patients with relapsed Non…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• IFOSFAMIDE (IFOSFAMIDE)
• Taxol (paclitaxel)
• Vumon (Teniposide)

Snippet

Sponsor: Northwestern University | Conditions: Lymphoma | Phase 1, Phase 2 | Status: COMPLETED